Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001674796-24-000026
Filing Date
2024-11-22
Accepted
2024-11-21 17:32:25
Documents
37
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 HST GLOBAL, INC. - FORM 10-Q SEC FILING hstc-20240930.htm   iXBRL 10-Q 221219
2 EXHIBIT 31.1 exhibit31-1.htm EX-31 8109
3 EXHIBIT 31.2 exhibit31-2.htm EX-31 8081
4 EXHIBIT 32.1 exhibit32-1.htm EX-32 3913
5 EXHIBIT 32.2 exhibit32-2.htm EX-32 3774
  Complete submission text file 0001674796-24-000026.txt   1282544

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hstc-20240930_cal.xml EX-101.CAL 15861
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hstc-20240930_def.xml EX-101.DEF 22467
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT hstc-20240930_lab.xml EX-101.LAB 85249
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hstc-20240930_pre.xml EX-101.PRE 66056
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hstc-20240930.xsd EX-101.SCH 13224
40 EXTRACTED XBRL INSTANCE DOCUMENT hstc-20240930_htm.xml XML 81670
Mailing Address 150 RESEARCH DR. HAMPTON VA 23666
Business Address 150 RESEARCH DR. HAMPTON VA 23666 757-766-6100
HST Global, Inc. (Filer) CIK: 0000797564 (see all company filings)

EIN.: 731215433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15303 | Film No.: 241485671
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)